Find Ocedurenone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ocedurenone [inn], Kbp5074, Kbp-5074, L46509378r, 1359969-24-6, 2-chloro-4-((3s,3ar)-3-cyclopentyl-7-((4-hydroxy-1-piperidinyl)carbonyl)-3,3a,4,5-tetrahydro-2h-pyrazolo(3,4-f)quinolin-2-yl)benzonitrile
Molecular Formula
C28H30ClN5O2
Molecular Weight
504.0  g/mol
InChI Key
UXHQLGLGLZKHTC-CUNXSJBXSA-N
FDA UNII
L46509378R

Ocedurenone
1 2D Structure

Ocedurenone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(3S,3aR)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo[3,4-f]quinolin-2-yl]-2-chlorobenzonitrile
2.1.2 InChI
InChI=1S/C28H30ClN5O2/c29-23-15-19(6-5-18(23)16-30)34-27(17-3-1-2-4-17)22-8-9-24-21(26(22)32-34)7-10-25(31-24)28(36)33-13-11-20(35)12-14-33/h5-7,10,15,17,20,22,27,35H,1-4,8-9,11-14H2/t22-,27-/m0/s1
2.1.3 InChI Key
UXHQLGLGLZKHTC-CUNXSJBXSA-N
2.1.4 Canonical SMILES
C1CCC(C1)C2C3CCC4=C(C3=NN2C5=CC(=C(C=C5)C#N)Cl)C=CC(=N4)C(=O)N6CCC(CC6)O
2.1.5 Isomeric SMILES
C1CCC(C1)[C@H]2[C@H]3CCC4=C(C3=NN2C5=CC(=C(C=C5)C#N)Cl)C=CC(=N4)C(=O)N6CCC(CC6)O
2.2 Other Identifiers
2.2.1 UNII
L46509378R
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-((3s,3as)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo(3,4-f)quinolin-2-yl)-2-chlorobenzonitrile

2. Kbp-5074

2.3.2 Depositor-Supplied Synonyms

1. Ocedurenone [inn]

2. Kbp5074

3. Kbp-5074

4. L46509378r

5. 1359969-24-6

6. 2-chloro-4-((3s,3ar)-3-cyclopentyl-7-((4-hydroxy-1-piperidinyl)carbonyl)-3,3a,4,5-tetrahydro-2h-pyrazolo(3,4-f)quinolin-2-yl)benzonitrile

7. Benzonitrile, 2-chloro-4-((3s,3ar)-3-cyclopentyl-3,3a,4,5-tetrahydro-7-((4-hydroxy-1-piperidinyl)carbonyl)-2h-pyrazolo(3,4-f)quinolin-2-yl)-

8. Schembl15048760

9. Gtpl12040

10. Unii-l46509378r

11. Example 12 [us9468635b2]

12. Hy-132827

13. Cs-0204111

14. 4-[(3s,3ar)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo[3,4-f]quinolin-2-yl]-2-chlorobenzonitrile

2.4 Create Date
2014-07-14
3 Chemical and Physical Properties
Molecular Weight 504.0 g/mol
Molecular Formula C28H30ClN5O2
XLogP34.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area92.8
Heavy Atom Count36
Formal Charge0
Complexity905
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty